Examining the Role of Deltalike3 in Notch Signaling During Vertebrate Segmentation
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Updates on the Role of Molecular Alterations and NOTCH Signalling in the Development of Neuroendocrine Neoplasms
Journal of Clinical Medicine Review Updates on the Role of Molecular Alterations and NOTCH Signalling in the Development of Neuroendocrine Neoplasms 1,2, 1, 3, 4 Claudia von Arx y , Monica Capozzi y, Elena López-Jiménez y, Alessandro Ottaiano , Fabiana Tatangelo 5 , Annabella Di Mauro 5, Guglielmo Nasti 4, Maria Lina Tornesello 6,* and Salvatore Tafuto 1,* On behalf of ENETs (European NeuroEndocrine Tumor Society) Center of Excellence of Naples, Italy 1 Department of Abdominal Oncology, Istituto Nazionale Tumori, IRCCS Fondazione “G. Pascale”, 80131 Naples, Italy 2 Department of Surgery and Cancer, Imperial College London, London W12 0HS, UK 3 Cancer Cell Metabolism Group. Centre for Haematology, Immunology and Inflammation Department, Imperial College London, London W12 0HS, UK 4 SSD Innovative Therapies for Abdominal Metastases—Department of Abdominal Oncology, Istituto Nazionale Tumori, IRCCS—Fondazione “G. Pascale”, 80131 Naples, Italy 5 Department of Pathology, Istituto Nazionale Tumori, IRCCS—Fondazione “G. Pascale”, 80131 Naples, Italy 6 Unit of Molecular Biology and Viral Oncology, Department of Research, Istituto Nazionale Tumori IRCCS Fondazione Pascale, 80131 Naples, Italy * Correspondence: [email protected] (M.L.T.); [email protected] (S.T.) These authors contributed to this paper equally. y Received: 10 July 2019; Accepted: 20 August 2019; Published: 22 August 2019 Abstract: Neuroendocrine neoplasms (NENs) comprise a heterogeneous group of rare malignancies, mainly originating from hormone-secreting cells, which are widespread in human tissues. The identification of mutations in ATRX/DAXX genes in sporadic NENs, as well as the high burden of mutations scattered throughout the multiple endocrine neoplasia type 1 (MEN-1) gene in both sporadic and inherited syndromes, provided new insights into the molecular biology of tumour development. -
Segmentation in Vertebrates: Clock and Gradient Finally Joined
Downloaded from genesdev.cshlp.org on September 24, 2021 - Published by Cold Spring Harbor Laboratory Press REVIEW Segmentation in vertebrates: clock and gradient finally joined Alexander Aulehla1 and Bernhard G. Herrmann2 Max-Planck-Institute for Molecular Genetics, Department of Developmental Genetics, 14195 Berlin, Germany The vertebral column is derived from somites formed by terior (A–P) axis. Somite formation takes place periodi- segmentation of presomitic mesoderm, a fundamental cally in a fixed anterior-to-posterior sequence. process of vertebrate embryogenesis. Models on the In the chick embryo, a new somite is formed approxi- mechanism controlling this process date back some mately every 90 min, whereas in the mouse embryo, the three to four decades. Access to understanding the mo- periodicity varies, dependent on the axial position (Tam lecular control of somitogenesis has been gained only 1981). Classical embryology experiments revealed that recently by the discovery of molecular oscillators (seg- periodicity and directionality of somite formation are mentation clock) and gradients of signaling molecules, controlled by an intrinsic program set off in the cells as as predicted by early models. The Notch signaling path- they are recruited into the psm. For instance, when the way is linked to the oscillator and plays a decisive role in psm is inverted rostro–caudally, somite formation in the inter- and intrasomitic boundary formation. An Fgf8 sig- inverted region proceeds from caudal to rostral, main- naling gradient is involved in somite size control. And taining the original direction (Christ et al. 1974). More- the (canonical) Wnt signaling pathway, driven by Wnt3a, over, neither the transversal bisection nor the isolation appears to integrate clock and gradient in a global of the psm from all surrounding tissues stops the seg- mechanism controlling the segmentation process. -
It's T-ALL About Notch
Oncogene (2008) 27, 5082–5091 & 2008 Macmillan Publishers Limited All rights reserved 0950-9232/08 $30.00 www.nature.com/onc REVIEW It’s T-ALL about Notch RM Demarest1, F Ratti1 and AJ Capobianco Molecular and Cellular Oncogenesis, The Wistar Institute, Philadelphia, PA, USA T-cell acute lymphoblastic leukemia (T-ALL) is an about T-ALL make it a more aggressive disease with a aggressive subset ofALL with poor clinical outcome poorer clinical outcome than B-ALL. T-ALL patients compared to B-ALL. Therefore, to improve treatment, it have a higher percentage of induction failure, and rate is imperative to delineate the molecular blueprint ofthis of relapse and invasion into the central nervous system disease. This review describes the central role that the (reviewed in Aifantis et al., 2008). The challenge to Notch pathway plays in T-ALL development. We also acquiring 100% remission in T-ALL treatment is the discuss the interactions between Notch and the tumor subset of patients (20–25%) whose disease is refractory suppressors Ikaros and p53. Loss ofIkaros, a direct to initial treatments or relapses after a short remission repressor ofNotch target genes, and suppression ofp53- period due to drug resistance. Therefore, it is imperative mediated apoptosis are essential for development of this to delineate the molecular blueprint that collectively neoplasm. In addition to the activating mutations of accounts for the variety of subtypes in T-ALL. This will Notch previously described, this review will outline allow for the development of targeted therapies that combinations ofmutations in pathways that contribute inhibit T-ALL growth by disrupting the critical path- to Notch signaling and appear to drive T-ALL develop- ways responsible for the neoplasm. -
Delta-Like Protein 3 Prevalence in Small Cell Lung Cancer and DLL3 (SP347) Assay Characteristics
EARLY ONLINE RELEASE Note: This article was posted on the Archives Web site as an Early Online Release. Early Online Release articles have been peer reviewed, copyedited, and reviewed by the authors. Additional changes or corrections may appear in these articles when they appear in a future print issue of the Archives. Early Online Release articles are citable by using the Digital Object Identifier (DOI), a unique number given to every article. The DOI will typically appear at the end of the abstract. The DOI for this manuscript is doi: 10.5858/arpa.2018-0497-OA The final published version of this manuscript will replace the Early Online Release version at the above DOI once it is available. © 2019 College of American Pathologists Original Article Delta-like Protein 3 Prevalence in Small Cell Lung Cancer and DLL3 (SP347) Assay Characteristics Richard S. P. Huang, MD; Burton F. Holmes, PhD; Courtney Powell; Raji V. Marati, PhD; Dusty Tyree, MS; Brittany Admire, PhD; Ashley Streator; Amy E. Hanlon Newell, PhD; Javier Perez, PhD; Deepa Dalvi; Ehab A. ElGabry, MD Context.—Delta-like protein 3 (DLL3) is a protein that is Results.—Cytoplasmic and/or membranous staining was implicated in the Notch pathway. observed in 1040 of 1362 specimens of small cell lung Objective.—To present data on DLL3 prevalence in cancer (76.4%). Homogenous and/or heterogeneous and small cell lung cancer and staining characteristics of the partial and/or circumferential granular staining with varied VENTANA DLL3 (SP347) Assay. In addition, the assay’s immunoreactivity with other neoplastic and nonneoplastic intensities was noted. -
SOMITOGENESIS in the CORN SNAKE Céline Gomez
SOMITOGENESIS IN THE CORN SNAKE Céline Gomez To cite this version: Céline Gomez. SOMITOGENESIS IN THE CORN SNAKE. Development Biology. Université Pierre et Marie Curie - Paris VI, 2007. English. NNT : 2007PA066439. tel-00807996 HAL Id: tel-00807996 https://tel.archives-ouvertes.fr/tel-00807996 Submitted on 4 Apr 2013 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. THESE DE DOCTORAT DE L’UNIVERSITE PIERRE ET MARIE CURIE Spécialité Biologie du Développement Présentée par Céline GOMEZ Pour obtenir le grade de DOCTEUR de l’UNIVERSITE PIERRE ET MARIE CURIE ETUDE DE LA SOMITOGENESE CHEZ LE SERPENT DES BLES Soutenue le 19 décembre 2007 Devant le jury composé de : Dr. Olivier POURQUIE: Directeur de thèse Dr. Guillaume BALAVOINE: Rapporteur Pr. Martin CATALA: Rapporteur Pr. Muriel UMBHAUER: Examinateur Pr. Denis DUBOULE: Examinateur 1 The Pierre et Marie Curie University SOMITOGENESIS IN THE CORN SNAKE A Thesis in Developmental Biology by Céline GOMEZ Submitted in Partial Fulfillement of the Requirements for the Degree of Doctor of Philosophy December 2007 2 ACKNOWLEDGMENTS I would like to heartily thank the Dr. Olivier Pourquié for his help in many ways. Thank you for having welcomed me in your team, whereas I was struggling to escape another laboratory, after having spent one year of my PhD. -
Somitogenesis in Amphibia IV
/. Embryol. exp. Morph. 76, 157-176 (1983) 257 Printed in Great Britain © The Company of Biologists Limited 1983 Somitogenesis in amphibia IV. The dynamics of tail development By TOM ELSDALE1 AND DUNCAN DAVIDSON From the MRC Clinical and Population Cytogenetics Unit, Western General Hospital, Edinburgh SUMMARY Following neurulation, the frog segments c.40 somites and concurrently undergoes a strik- ing elongation along the anteroposterior axis. This elongation (excluding the head) is largely the result of a presegmental extension of posterior tissue with a lesser contribution from the extension of segmented tissue. Presegmental extension is entirely the result of activity within a narrow zone of extension that occupies the central region in the tail bud. Within the zone of extension, a minimum of six prospective somites undergo an eight- to ten-fold extension along the axis. The zone passes posteriorly across the tissue of the tail tip. The anterior of the tail bud contains three extended prospective somites in the course of segmentation. The anterior boundary of the zone of extension coincides in space exactly with the anterior boundary of the zone of abnormal seg- mentation that results from temperature shock. This means that extension ceases immediately before the sudden tissue change associated with segmentation. INTRODUCTION There are thirteen paired myotomes in the adult frog, and some forty pairs in the tadpole. Two thirds of the somites segmented in the embryo are therefore tail somites. Previous accounts of tail development have been concerned with the origins of the parts of the tail in early development and the fate map on the early gastrula (Pasteels, 1939). -
Coactivation of NF-Kb and Notch Signaling Is Sufficient to Induce B
Regular Article LYMPHOID NEOPLASIA Coactivation of NF-kB and Notch signaling is sufficient to induce B-cell transformation and enables B-myeloid conversion Downloaded from https://ashpublications.org/blood/article-pdf/135/2/108/1550992/bloodbld2019001438.pdf by UNIV OF IOWA LIBRARIES user on 20 February 2020 Yan Xiu,1,* Qianze Dong,1,2,* Lin Fu,1,2 Aaron Bossler,1 Xiaobing Tang,1,2 Brendan Boyce,3 Nicholas Borcherding,1 Mariah Leidinger,1 Jose´ Luis Sardina,4,5 Hai-hui Xue,6 Qingchang Li,2 Andrew Feldman,7 Iannis Aifantis,8 Francesco Boccalatte,8 Lili Wang,9 Meiling Jin,9 Joseph Khoury,10 Wei Wang,10 Shimin Hu,10 Youzhong Yuan,11 Endi Wang,12 Ji Yuan,13 Siegfried Janz,14 John Colgan,15 Hasem Habelhah,1 Thomas Waldschmidt,1 Markus Muschen,¨ 9 Adam Bagg,16 Benjamin Darbro,17 and Chen Zhao1,18 1Department of Pathology, Carver College of Medicine, University of Iowa, Iowa City, IA; 2Department of Pathology, China Medical University, Shenyang, China; 3Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, Rochester, NY; 4Gene Regulation, Stem Cells and Cancer Program, Centre for Genomic Regulation, Barcelona Institute of Science and Technology, Barcelona, Spain; 5Josep Carreras Leukaemia Research Institute, Campus ICO-Germans Trias i Pujol, Barcelona, Spain; 6Department of Microbiology and Immunology, Carver College of Medicine, University of Iowa, Iowa City, IA; 7Department of Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Rochester, MN; 8Department of Pathology, NYU School of Medicine, -
Stages of Embryonic Development of the Zebrafish
DEVELOPMENTAL DYNAMICS 2032553’10 (1995) Stages of Embryonic Development of the Zebrafish CHARLES B. KIMMEL, WILLIAM W. BALLARD, SETH R. KIMMEL, BONNIE ULLMANN, AND THOMAS F. SCHILLING Institute of Neuroscience, University of Oregon, Eugene, Oregon 97403-1254 (C.B.K., S.R.K., B.U., T.F.S.); Department of Biology, Dartmouth College, Hanover, NH 03755 (W.W.B.) ABSTRACT We describe a series of stages for Segmentation Period (10-24 h) 274 development of the embryo of the zebrafish, Danio (Brachydanio) rerio. We define seven broad peri- Pharyngula Period (24-48 h) 285 ods of embryogenesis-the zygote, cleavage, blas- Hatching Period (48-72 h) 298 tula, gastrula, segmentation, pharyngula, and hatching periods. These divisions highlight the Early Larval Period 303 changing spectrum of major developmental pro- Acknowledgments 303 cesses that occur during the first 3 days after fer- tilization, and we review some of what is known Glossary 303 about morphogenesis and other significant events that occur during each of the periods. Stages sub- References 309 divide the periods. Stages are named, not num- INTRODUCTION bered as in most other series, providing for flexi- A staging series is a tool that provides accuracy in bility and continued evolution of the staging series developmental studies. This is because different em- as we learn more about development in this spe- bryos, even together within a single clutch, develop at cies. The stages, and their names, are based on slightly different rates. We have seen asynchrony ap- morphological features, generally readily identi- pearing in the development of zebrafish, Danio fied by examination of the live embryo with the (Brachydanio) rerio, embryos fertilized simultaneously dissecting stereomicroscope. -
Notch Signaling: Simplicity in Design, Versatility in Function Emma R
REVIEW 3593 Development 138, 3593-3612 (2011) doi:10.1242/dev.063610 © 2011. Published by The Company of Biologists Ltd Notch signaling: simplicity in design, versatility in function Emma R. Andersson1, Rickard Sandberg2 and Urban Lendahl1,* Summary different cell types and organs have recently been reviewed (Liu et Notch signaling is evolutionarily conserved and operates in al., 2010) and are summarized in Table 1. In keeping with its many cell types and at various stages during development. important role in many cell types, the mutation of Notch genes Notch signaling must therefore be able to generate leads to diseases in various organs and tissues (Table 2). These appropriate signaling outputs in a variety of cellular contexts. studies highlight the fact that the Notch pathway must be able to This need for versatility in Notch signaling is in apparent elicit appropriate responses in many spatially and temporally contrast to the simple molecular design of the core pathway. distinct cell contexts. Here, we review recent studies in nematodes, Drosophila and In this review, we address the conundrum of how this functional vertebrate systems that begin to shed light on how versatility diversity is compatible with the simplistic molecular design of the in Notch signaling output is generated, how signal strength is Notch signaling pathway. In particular, we focus on recent modulated, and how cross-talk between the Notch pathway observations, in both vertebrate and invertebrate systems, that and other intracellular signaling systems, such as the Wnt, begin to shed light on how diversity is generated at different steps hypoxia and BMP pathways, contributes to signaling diversity. -
Understanding Paraxial Mesoderm Development and Sclerotome Specification for Skeletal Repair Shoichiro Tani 1,2, Ung-Il Chung2,3, Shinsuke Ohba4 and Hironori Hojo2,3
Tani et al. Experimental & Molecular Medicine (2020) 52:1166–1177 https://doi.org/10.1038/s12276-020-0482-1 Experimental & Molecular Medicine REVIEW ARTICLE Open Access Understanding paraxial mesoderm development and sclerotome specification for skeletal repair Shoichiro Tani 1,2, Ung-il Chung2,3, Shinsuke Ohba4 and Hironori Hojo2,3 Abstract Pluripotent stem cells (PSCs) are attractive regenerative therapy tools for skeletal tissues. However, a deep understanding of skeletal development is required in order to model this development with PSCs, and for the application of PSCs in clinical settings. Skeletal tissues originate from three types of cell populations: the paraxial mesoderm, lateral plate mesoderm, and neural crest. The paraxial mesoderm gives rise to the sclerotome mainly through somitogenesis. In this process, key developmental processes, including initiation of the segmentation clock, formation of the determination front, and the mesenchymal–epithelial transition, are sequentially coordinated. The sclerotome further forms vertebral columns and contributes to various other tissues, such as tendons, vessels (including the dorsal aorta), and even meninges. To understand the molecular mechanisms underlying these developmental processes, extensive studies have been conducted. These studies have demonstrated that a gradient of activities involving multiple signaling pathways specify the embryonic axis and induce cell-type-specific master transcription factors in a spatiotemporal manner. Moreover, applying the knowledge of mesoderm development, researchers have attempted to recapitulate the in vivo development processes in in vitro settings, using mouse and human PSCs. In this review, we summarize the state-of-the-art understanding of mesoderm development and in vitro modeling of mesoderm development using PSCs. We also discuss future perspectives on the use of PSCs to generate skeletal tissues for basic research and clinical applications. -
NOTCH1 Gene Notch 1
NOTCH1 gene notch 1 Normal Function The NOTCH1 gene provides instructions for making a protein called Notch1, a member of the Notch family of receptors. Receptor proteins have specific sites into which certain other proteins, called ligands, fit like keys into locks. Attachment of a ligand to the Notch1 receptor sends signals that are important for normal development of many tissues throughout the body, both before birth and after. Notch1 signaling helps determine the specialization of cells into certain cell types that perform particular functions in the body (cell fate determination). It also plays a role in cell growth and division (proliferation), maturation (differentiation), and self-destruction (apoptosis). The protein produced from the NOTCH1 gene has such diverse functions that the gene is considered both an oncogene and a tumor suppressor. Oncogenes typically promote cell proliferation or survival, and when mutated, they have the potential to cause normal cells to become cancerous. In contrast, tumor suppressors keep cells from growing and dividing too fast or in an uncontrolled way, preventing the development of cancer; mutations that impair tumor suppressors can lead to cancer development. Health Conditions Related to Genetic Changes Adams-Oliver syndrome At least 15 mutations in the NOTCH1 gene have been found to cause Adams-Oliver syndrome, a condition characterized by areas of missing skin (aplasia cutis congenita), usually on the scalp, and malformations of the hands and feet. These mutations are usually inherited and are present in every cell of the body. Some of the NOTCH1 gene mutations involved in Adams-Oliver syndrome lead to production of an abnormally short protein that is likely broken down quickly, causing a shortage of Notch1. -
Notch Signaling in Breast Cancer: a Role in Drug Resistance
cells Review Notch Signaling in Breast Cancer: A Role in Drug Resistance McKenna BeLow 1 and Clodia Osipo 1,2,3,* 1 Integrated Cell Biology Program, Loyola University Chicago, Maywood, IL 60513, USA; [email protected] 2 Department of Cancer Biology, Loyola University Chicago, Maywood, IL 60513, USA 3 Department of Microbiology and Immunology, Loyola University Chicago, Maywood, IL 60513, USA * Correspondence: [email protected]; Tel.: +1-708-327-2372 Received: 12 September 2020; Accepted: 28 September 2020; Published: 29 September 2020 Abstract: Breast cancer is a heterogeneous disease that can be subdivided into unique molecular subtypes based on protein expression of the Estrogen Receptor, Progesterone Receptor, and/or the Human Epidermal Growth Factor Receptor 2. Therapeutic approaches are designed to inhibit these overexpressed receptors either by endocrine therapy, targeted therapies, or combinations with cytotoxic chemotherapy. However, a significant percentage of breast cancers are inherently resistant or acquire resistance to therapies, and mechanisms that promote resistance remain poorly understood. Notch signaling is an evolutionarily conserved signaling pathway that regulates cell fate, including survival and self-renewal of stem cells, proliferation, or differentiation. Deregulation of Notch signaling promotes resistance to targeted or cytotoxic therapies by enriching of a small population of resistant cells, referred to as breast cancer stem cells, within the bulk tumor; enhancing stem-like features during the process of de-differentiation of tumor cells; or promoting epithelial to mesenchymal transition. Preclinical studies have shown that targeting the Notch pathway can prevent or reverse resistance through reduction or elimination of breast cancer stem cells. However, Notch inhibitors have yet to be clinically approved for the treatment of breast cancer, mainly due to dose-limiting gastrointestinal toxicity.